Procept ( PRCT ) Q2 Revenue Jumps 48%
Procept BioRobotics ( NASDAQ:PRCT ) , a medical technology company specializing in robotic surgical systems for benign prostatic hyperplasia ( BPH ) treatment, posted second-quarter 2025 results on August 6, 2025. The company reported GAAP revenue of $79.2 million, surpassing analyst estimates.
PROCEPT BioRobotics Corporation ( PRCT ) Reports Q2 Loss, Lags Revenue Estimates
PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of +14.63% and -0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PROCEPT BioRobotics ( PRCT ) Earnings Transcript
Image source: The Motley Fool.Aug. 6, 2025, 8:30 p.m. ETChief Executive Officer - Reza ZadnoContinue reading ...
AxoGen ( AXGN ) Beats Q2 Earnings and Revenue Estimates
AxoGen (AXGN) delivered earnings and revenue surprises of +100.00% and +7.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Si-Bone ( SIBN ) Reports Q2 Loss, Beats Revenue Estimates
Si-Bone (SIBN) delivered earnings and revenue surprises of +26.32% and +0.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Envoy Medical, Inc. ( COCH ) Reports Q2 Loss, Tops Revenue Estimates
Envoy Medical, Inc. (COCH) delivered earnings and revenue surprises of -10.34% and +39.29%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Will PROCEPT BioRobotics Corporation ( PRCT ) Report Negative Earnings Next Week? What You Should Know
PROCEPT BioRobotics (PRCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
SAN JOSE, Calif., July 24, 2025 ( GLOBE NEWSWIRE ) -- PROCEPT BioRobotics ( Nasdaq: PRCT ) ( "the Company" ) , a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that Larry L.
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO - PROCEPT BioRobotics ( NASDAQ:PRCT )
Larry L. Wood to join PROCEPT BioRobotics effective September 2, 2025 Company confirms strong underlying business trends and pre-announces 2Q25 revenue of approximately $79.2 million, representing annual growth of 48%
Aquablation® Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule - PROCEPT BioRobotics ( NASDAQ:PRCT )
SAN JOSE, Calif., July 14, 2025 ( GLOBE NEWSWIRE ) -- PROCEPT BioRobotics® Corporation PRCT ( the "Company" ) , a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that Aquablation therapy was assigned a Category I code ...
Aquablation® Therapy's Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
SAN JOSE, Calif., July 14, 2025 ( GLOBE NEWSWIRE ) -- PROCEPT BioRobotics® Corporation ( Nasdaq: PRCT ) ( the "Company" ) , a surgical robotics company dedicated to advancing patient care through transformative urology solutions, today announced that Aquablation therapy was assigned a Category I ...
PROCEPT BioRobotics Corporation ( PRCT ) Reports Q1 Loss, Tops Revenue Estimates
PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of 8.16% and 5.77%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada - PROCEPT BioRobotics ( NASDAQ:PRCT )
SAN JOSE, Calif., March 14, 2025 ( GLOBE NEWSWIRE ) -- PROCEPT BioRobotics Corporation PRCT ( the "Company" ) , a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today it will host an in-person investor event on Friday, ...
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada
SAN JOSE, Calif., March 14, 2025 ( GLOBE NEWSWIRE ) -- PROCEPT BioRobotics Corporation ( Nasdaq: PRCT ) ( the "Company" ) , a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today it will host an in-person investor event on ...
PROCEPT BioRobotics Corporation ( PRCT ) Reports Q4 Loss, Tops Revenue Estimates
PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of 0% and 2.40%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Penumbra ( PEN ) Beats Q4 Earnings and Revenue Estimates
Penumbra (PEN) delivered earnings and revenue surprises of 6.59% and 1.07%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference
SAN JOSE, Calif., Feb. 07, 2025 ( GLOBE NEWSWIRE ) -- PROCEPT BioRobotics ( Nasdaq: PRCT ) ( the "Company" ) , a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the fourth quarter ...
How Is The Market Feeling About PROCEPT BioRobotics? - PROCEPT BioRobotics ( NASDAQ:PRCT )
PROCEPT BioRobotics's PRCT short percent of float has risen 11.46% since its last report. The company recently reported that it has 6.89 million shares sold short, which is 17.21% of all regular shares that are available for trading.
Spruce Point Sees Trouble Ahead For Procept BioRobotics - PROCEPT BioRobotics ( NASDAQ:PRCT )
On Thursday, Spruce Point Capital released a detailed report on PROCEPT BioRobotics PRCT, raising concerns about the claims surrounding its market potential and growth prospects, suggesting the company's stock could face a 30% to 60% downside.
PROCEPT BioRobotics ( PRCT ) Upgraded to Strong Buy: Here's What You Should Know
PROCEPT BioRobotics (PRCT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos - Baxter Intl ( NYSE:BAX ) , DexCom ( NASDAQ:DXCM )
Last year, Morgan Stanley upgraded its outlook for the U.S. MedTech sector to "Attractive," believing the concerns around GLP-1s were already reflected in stock prices and that fundamentals were strong.
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Autodesk ( NASDAQ:ADSK ) , MediciNova ( NASDAQ:MNOV )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. D. Boral Capital analyst Jason Kolbert initiated coverage on MediciNova, Inc.
Looking Into PROCEPT BioRobotics's Recent Short Interest - PROCEPT BioRobotics ( NASDAQ:PRCT )
PROCEPT BioRobotics's PRCT short percent of float has fallen 16.86% since its last report. The company recently reported that it has 5.90 million shares sold short, which is 14.74% of all regular shares that are available for trading.
Are You Looking for a Top Momentum Pick? Why PROCEPT BioRobotics Corporation ( PRCT ) is a Great Choice
Does PROCEPT BioRobotics Corporation (PRCT) have what it takes to be a top stock pick for momentum investors? Let's find out.
PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock
SAN JOSE, Calif., Oct. 29, 2024 ( GLOBE NEWSWIRE ) -- PROCEPT BioRobotics® Corporation ( NASDAQ: PRCT ) ( "PROCEPT BioRobotics" or the "Company" ) , a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced the pricing of an ...
All You Need to Know About PROCEPT BioRobotics ( PRCT ) Rating Upgrade to Strong Buy
PROCEPT BioRobotics (PRCT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Stock Market News for Oct 29, 2024
U.S. stocks ended higher on Monday as investors braced for big tech earnings and economic reports. The diminishing geopolitical crisis in the Middle East also boosted investors' sentiment. Israel's limited offense on Iran led to a decline in oil prices.
PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock
SAN JOSE, Calif., Oct. 28, 2024 ( GLOBE NEWSWIRE ) -- PROCEPT BioRobotics® Corporation ( NASDAQ: PRCT ) ( "PROCEPT BioRobotics" or the "Company" ) , a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced the commencement ...
Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential - PROCEPT BioRobotics ( NASDAQ:PRCT )
PROCEPT BioRobotics PRCT stock is trading on Monday after the company released better-than-expected third-quarter earnings. The company reported EPS loss of $ ( 0.40 ) , down from $ ( 0.51 ) a year ago, beating the consensus loss of $ ( 0.49 ) .
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday - PROCEPT BioRobotics ( NASDAQ:PRCT )
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on Monday. Shares of PROCEPT BioRobotics Corporation PRCT rose sharply during Monday's session after the company reported better-than-expected third-quarter financial results and raised its FY24 revenue guidance.
PROCEPT BioRobotics Corporation ( PRCT ) Reports Q3 Loss, Tops Revenue Estimates
PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of 16.67% and 9.56%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Down -15.71% in 4 Weeks, Here's Why PROCEPT BioRobotics ( PRCT ) Looks Ripe for a Turnaround
PROCEPT BioRobotics (PRCT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Earnings Preview: Teleflex ( TFX ) Q3 Earnings Expected to Decline
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PROCEPT BioRobotics Corporation ( PRCT ) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
PROCEPT BioRobotics (PRCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PRCT Stock Rises on FDA's Nod to Initiate Study on Prostate Cancer
PROCEPT BioRobotics receives FDA's approval to begin a pivotal randomized clinical study to assess the use of Aquablation therapy in treating prostate cancer patients.
Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good' - Zoetis ( NYSE:ZTS )
On CNBC's "Mad Money Lightning Round," Jim Cramer said Target Corporation TGT reported a "very, very good" quarter. "It does yield 3%, which is actually quite good," he added.
PROCEPT BioRobotics' HYDROS System Gets FDA Clearance - Quest Diagnostics ( NYSE:DGX ) , ABM Indus ( NYSE:ABM )
PROCEPT BioRobotics PRCT recently announced FDA 510 ( k ) clearance of its next-generation platform, the HYDROS Robotic System. This clearance marks an important achievement for PROCEPT BioRobotics as Aquablation therapy continues its rapid adoption, with more than 400 robotic systems now ...
PROCEPT BioRobotics' ( PRCT ) HYDROS System Gets FDA Clearance
PROCEPT BioRobotics (PRCT) announces the FDA 510(k) clearance of its HYDROS Robotic System for providing better BPH treatment.
PROCEPT ( PRCT ) Grows in Urology With FDA Clearance for HYDROS
PROCEPT's (PRCT) HYDROS Robotic System leverages AI-driven technology, specifically FirstAssist AI, to optimize treatment planning.
Nasdaq Gains 0.5%; TJX Earnings Top Estimates - TJX Companies ( NYSE:TJX )
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 0.5% on Wednesday. The Dow traded up 0.08% to 40,867.75 while the NASDAQ rose 0.49% to 17,903.01. The S&P 500 also rose, gaining, 0.37% to 5,618.02. Consumer discretionary shares climbed by 1.2% on ...
Toll Brothers Posts Strong Earnings, Joins Keysight, Coty, TJX And Other Big Stocks Moving Higher On Wednesday - Toll Brothers ( NYSE:TOL )
U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Wednesday. Shares of Toll Brothers, Inc. TOL rose sharply during Wednesday's session after the company reported better-than-expected third-quarter financial results and issued FY24 EPS guidance above estimates.
PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy - PROCEPT BioRobotics ( NASDAQ:PRCT )
SAN JOSE, Calif., Aug. 21, 2024 ( GLOBE NEWSWIRE ) -- PROCEPT BioRobotics® Corporation PRCT ( the "Company" ) , a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced FDA 510 ( k ) clearance of its next-generation ...
PROCEPT BioRobotics Corporation ( PRCT ) Reports Q2 Loss, Tops Revenue Estimates
PROCEPT BioRobotics (PRCT) delivered earnings and revenue surprises of 3.85% and 6.08%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Is First Trust Small Cap Growth AlphaDEX ETF ( FYC ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Should First Trust Small Cap Growth AlphaDEX ETF ( FYC ) Be on Your Investing Radar?
Style Box ETF report for ...
Should First Trust Small Cap Core AlphaDEX ETF ( FYX ) Be on Your Investing Radar?
Style Box ETF report for ...
PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy - PROCEPT BioRobotics ( NASDAQ:PRCT )
SAN JOSE, Calif., June 17, 2024 ( GLOBE NEWSWIRE ) -- PROCEPT BioRobotics® Corporation PRCT ( the "Company" ) , a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that the American Medical Association ( "AMA" ) has ...
Intuitive Surgical, IBD Stock Of The Day, Feels Its Way Toward Buy Point
Intuitive Surgical, SOTD, Feels Near Buy Point Investor's Business Daily ...
PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference
SAN JOSE, Calif., May 13, 2024 ( GLOBE NEWSWIRE ) -- PROCEPT BioRobotics® ( Nasdaq: PRCT ) ( the "Company" ) , a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming ...
The Robotic Surgeon Will See You Now
Intuitive Surgical Stock Builds On Its Robotic Surgery Prowess, But Challengers Loom Investor's Business Daily ...
